DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🟢 Decoy Therapeutics is trading 5.79% up in after-hours trading after warrant financing raised about $3.85 million
Decoy Therapeutics is trading 5.79% up at $3.29 in after-hours trading after warrant-inducement financing delivered approximately $3.85 million in gross...
🔴 Decoy Therapeutics is trading 11.43% down today as immediately exercisable warrants intensify dilution pressure
Decoy Therapeutics is trading 11.43% lower at $3.41 after its September 23, 2026 warrant-inducement financing created dilution pressure. - The transaction...
🔴 Decoy Therapeutics is trading 8.31% down today as immediately exercisable warrants add dilution pressure
Decoy Therapeutics is trading 8.31% down at $3.53, with the warrant-inducement financing creating the clearest pressure. - Shares are pulling back after...
🔴 Decoy Therapeutics is trading 7.4% down today in pre-market amid warrant-inducement financing overhang
Decoy Therapeutics is trading 7.4% down now in pre-market at $3.56, with warrant-inducement financing overhang following a sharp two-session rally. - The $3.85...
Decoy Therapeutics Raises $3.85M via Warrant Inducement Transaction
Decoy Therapeutics Inc. entered into a warrant inducement agreement with an institutional investor, raising approximately $3.85 million in gross proceeds. The...
🟢 Decoy Therapeutics is trading 48.71% up today after announcing a pan-filovirus antiviral program
Decoy Therapeutics is trading 48.71% up at $4.61 after announcing a pan-filovirus antiviral program on September 22, 2026, targeting Ebola and Marburg viruses...
🟢 Decoy Therapeutics is trading 19% up in pre-market after announcing pan-filovirus antiviral program
Decoy Therapeutics is trading at $3.69, up +19.03%, after announcing a pan-filovirus antiviral program targeting Ebola and Marburg viruses. - The program is...
🟢 Decoy Therapeutics is trading 12.58% up in after-hours trading after announcing a pan-filovirus antiviral program
Decoy Therapeutics is trading 12.58% up at $3.49 after announcing a pan-filovirus antiviral program targeting Ebola and Marburg viruses through the FDA’s...
🟢 Decoy Therapeutics is trading 7% up in after-hours trading after announcing its Ebola-Marburg antiviral program
Decoy Therapeutics is trading 7.10% higher at $3.32 after announcing a pan-filovirus program targeting Ebola and Marburg viruses through the FDA’s Animal Rule...
Decoy Therapeutics Doubles on an Ebola Drug Bet — But Can a Micro-Cap With 11 Employees Actually Deliver?
Shares of Decoy Therapeutics (DCOY) exploded +131% to $5.92 on September 22, after the Cambridge-based biotech unveiled a plan to develop a broad antiviral...
🟢 Decoy Therapeutics is trading 133% up today after announcing FDA Animal Rule pan-filovirus program
Decoy Therapeutics is trading at $5.92 (+132.61%) after announcing a pan-filovirus program using the FDA Animal Rule pathway on September 22, 2026. - Reported...
🟢 Decoy Therapeutics is trading 61.53% up in pre-market with no clear catalyst identified
Decoy Therapeutics is trading at $4.11, up 61.53% in pre-market, with no clear explanation identified. - No fresh company-specific announcement or overnight...
🔴 Decoy Therapeutics is trading 11.9% down today with no fresh catalyst identified
Decoy Therapeutics is trading 11.87% down now at $2.45 after no fresh company-specific catalyst was identified for September 21, 2026. - The latest notable...
🟢 Decoy Therapeutics is trading 13% up in pre-market
Decoy Therapeutics is trading 12.72% up at $3.19 in pre-market, with no fresh company-specific catalyst identified. - Latest notable news was September 15...
🟢 Decoy Therapeutics is trading 5.9% up today after shareholder approval of warrant issuance
Decoy Therapeutics is trading at $2.87, up +5.90%, as the move may reflect continued reaction to shareholders approving warrant issuance and reducing...
🟢 Decoy Therapeutics is trading 13.45% up in after-hours trading with no confirmed company-specific catalyst
Decoy Therapeutics is trading 13.45% up at $3.07 in after-hours trading, with no confirmed company-specific catalyst identified for the move. - It closed at...
🟢 Decoy Therapeutics is trading 9.59% up in after-hours trading — no confirmed company-specific catalyst identified
Decoy Therapeutics is trading 9.59% up at $2.97 after no confirmed company-specific catalyst was identified for the September 15, 2026 after-hours move. -...
🔴 Decoy Therapeutics is trading 4.4% down in pre-market with no confirmed catalyst
Decoy Therapeutics is trading 4.4% down at $2.59, with no confirmed company announcement explaining the pre-market decline. - It closed at $2.71 on September...
🟢 Decoy Therapeutics is trading 15.07% up in pre-market as shareholder meeting results remain pending
Decoy Therapeutics is trading at $3.12 (+15.07%) after closing at $2.71 on September 14, with no confirmed announcement directly explaining the pre-market...
🟢 Decoy Therapeutics is trading 10.34% up in after-hours trading
Decoy Therapeutics is trading 10.34% up at $2.99 after closing at $2.71 on September 14, 2026; no confirmed company announcement directly explains the...